{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:34:43Z","timestamp":1785173683767,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018692","name":"\u00c9cole Normale Sup\u00e9rieure de Lyon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006537","name":"Campus France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007241","name":"Universit\u00e9 Paris-Saclay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.biopha.2026.119060","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:54:31Z","timestamp":1770051271000},"page":"119060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Inhibition of TRAP1 in the C-terminal domain influences mitochondria properties and breast cancer cell metabolism"],"prefix":"10.1016","volume":"196","author":[{"given":"Cl\u00e9lia","family":"Mathieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Ristow","family":"Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Zancan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Messaoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Fattal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Vergnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119060_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2017.01.013","article-title":"Heat shock proteins and cancer: how can nanomedicine be harnessed?","volume":"248","author":"Sauvage","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119060_bib2","doi-asserted-by":"crossref","DOI":"10.20517\/cdr.2019.26","article-title":"Cancer drug resistance: rationale for drug delivery systems and targeted inhibition of HSP90 family proteins","author":"Mathieu","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.biopha.2026.119060_bib3","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1042\/BCJ20160005","article-title":"Mechanisms of Hsp90 regulation","volume":"473","author":"Prodromou","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2026.119060_bib4","doi-asserted-by":"crossref","unstructured":"Hayat U., Elliott G.T., Olszanski A.J., Altieri D.C. Feasibility and safety of targeting mitochondria for cancer therapy \u2013 preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhibitor. Cancer Biol Ther. 23:117\u2013126.","DOI":"10.1080\/15384047.2022.2029132"},{"key":"10.1016\/j.biopha.2026.119060_bib5","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1039\/C4CC07284G","article-title":"N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes","volume":"51","author":"Wang","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.biopha.2026.119060_bib6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1021\/ml500114p","article-title":"Chemically accessible Hsp90 inhibitor that does not induce a heat shock response","volume":"5","author":"Koay","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2026.119060_bib7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/cmdc.201000489","article-title":"Discovery and biological activity of 6BrCaQ as an inhibitor of the Hsp90 protein folding machinery","volume":"6","author":"Audisio","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.biopha.2026.119060_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.canlet.2018.06.001","article-title":"Antitumor activity of nanoliposomes encapsulating the novobiocin analog 6BrCaQ in a triple-negative breast cancer model in mice","volume":"432","author":"Sauvage","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119060_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2015.12.053","article-title":"Formulation and in vitro efficacy of liposomes containing the Hsp90 inhibitor 6BrCaQ in prostate cancer cells","volume":"499","author":"Sauvage","year":"2016","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.biopha.2026.119060_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114052","article-title":"Synthesis and antiproliferative activity of 6BrCaQ-TPP conjugates for targeting the mitochondrial heat shock protein TRAP1","volume":"229","author":"Mathieu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119060_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/genes9040195","article-title":"TRAP1 regulation of cancer metabolism: dual role as oncogene or tumor suppressor","volume":"9","author":"Matassa","year":"2018","journal-title":"Genes"},{"key":"10.1016\/j.biopha.2026.119060_bib12","doi-asserted-by":"crossref","first-page":"44495","DOI":"10.18632\/oncotarget.6252","article-title":"Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119060_bib13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1158\/1541-7786.MCR-13-0481","article-title":"TRAP1 Regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC","volume":"12","author":"Agorreta","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119060_bib14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.molonc.2013.04.009","article-title":"Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1","volume":"7","author":"Maddalena","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biopha.2026.119060_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr2889","article-title":"Choosing the right cell line for breast cancer research","volume":"13","author":"Holliday","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.biopha.2026.119060_bib16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1186\/s12885-020-07414-y","article-title":"Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: impact of non-cytotoxic doses of 2-DG on diminishing invasiveness","volume":"20","author":"Fujita","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2026.119060_bib17","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1016\/j.bbadis.2017.08.030","article-title":"MDA-MB-231 breast cancer cells fuel osteoclast metabolism and activity: a new rationale for the pathogenesis of osteolytic bone metastases","volume":"1863","author":"Lemma","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2026.119060_bib18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/febs.14756","article-title":"Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes","volume":"286","author":"Lunetti","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2026.119060_bib19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s13058-014-0434-6","article-title":"Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential","volume":"16","author":"Pelicano","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.biopha.2026.119060_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.400","article-title":"TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial\u2013mesenchymal transition","volume":"7","author":"Amoroso","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2026.119060_bib21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10585-008-9169-z","article-title":"Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity","volume":"25","author":"Hughes","year":"2008","journal-title":"Clin. Exp. Metastas."},{"key":"10.1016\/j.biopha.2026.119060_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mito.2020.08.001","article-title":"Mitochondrial chaperone, TRAP1 modulates mitochondrial dynamics and promotes tumor metastasis","volume":"54","author":"Purushottam Dharaskar","year":"2020","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biopha.2026.119060_bib23","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1073\/pnas.1015181108","article-title":"Benzoquinone ansamycin 17AAG binds to mitochondrial voltage-dependent anion channel and inhibits cell invasion","volume":"108","author":"Xie","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119060_bib24","doi-asserted-by":"crossref","first-page":"16155","DOI":"10.1021\/acs.jmedchem.2c01633","article-title":"Structure, function, and inhibitors of the mitochondrial chaperone TRAP1","volume":"65","author":"Kang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119060_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41964","article-title":"Targeting epithelial-mesenchymal transition signaling pathways with dietary phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers","volume":"11","author":"Sravani","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2026.119060_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41598-017-18582-6","article-title":"Uncoupled mitochondria quickly shorten along their long axis to form indented spheroids, instead of rings, in a fission-independent manner","volume":"8","author":"Miyazono","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119060_bib27","first-page":"16155","article-title":"Structure, function, and inhibitors of the mitochondrial chaperone TRAP1","volume":"65","author":"Kang","year":"2022","journal-title":"J. Med. Chem. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2026.119060_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130395","article-title":"TRAP1 and its therapeutic potential","volume":"129","author":"Gutierrez","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2026.119060_bib29","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cmet.2013.04.019","article-title":"The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase","volume":"17","author":"Sciacovelli","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2026.119060_bib30","article-title":"PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1","volume":"5","author":"Pridgeon","year":"2007"},{"key":"10.1016\/j.biopha.2026.119060_bib31","first-page":"562","article-title":"Topology-dependent, bifurcated mitochondrial quality control under starvation","volume":"16","author":"Zhou","year":"2020"},{"key":"10.1016\/j.biopha.2026.119060_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051912","article-title":"TRAP1 controls mitochondrial fusion\/fission balance through Drp1 and Mff expression","volume":"7","author":"Takamura","year":"2012","journal-title":"PLOS One"},{"key":"10.1016\/j.biopha.2026.119060_bib33","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1172\/JCI37613","article-title":"Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90","volume":"119","author":"Kang","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2026.119060_bib34","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1158\/1078-0432.CCR-10-1818","article-title":"Preclinical characterization of mitochondria-targeted small molecule Hsp90 inhibitors, gamitrinibs, in advanced prostate cancer","volume":"16","author":"Kang","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119060_bib35","article-title":"Computational classification of mitochondrial shapes reflects stress and redox state","volume":"4","author":"Ahmad","year":"2013"},{"key":"10.1016\/j.biopha.2026.119060_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fonc.2017.00058","article-title":"The chaperone TRAP1 As a modulator of the mitochondrial adaptations in cancer cells","volume":"7","author":"Masgras","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2026.119060_bib37","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1038\/s41598-017-09206-0","article-title":"Bioenergetic adaptations in chemoresistant ovarian cancer cells","volume":"7","author":"Dar","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119060_bib38","doi-asserted-by":"crossref","first-page":"C125","DOI":"10.1038\/ncomms3139","article-title":"Landscape of the mitochondrial Hsp90 metabolome in tumours","volume":"4","author":"Chae","year":"2013","journal-title":"Nat. Commun."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:40:00Z","timestamp":1781880000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226000922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":38,"alternative-id":["S0753332226000922"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119060","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of TRAP1 in the C-terminal domain influences mitochondria properties and breast cancer cell metabolism","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119060"}}